Inventor · disambiguated record
Sanjiv Ghanshani
Also filed as: GHANSHANI SANJIV
18 granted patents·11 pending applications·222 citations·filing 2007–2022
95Inventor score
Top patents by PatentIndex Score
29 records- 0199US7897157B2Activatable clostridial toxinsALLERGAN INC·Filed 2007·Granted Mar 1, 2011·62 cites·29 claims
- 0298US7740868B2Activatable clostridial toxinsALLERGAN INC·Filed 2007·Granted Jun 22, 2010·63 cites·34 claims
- 0397US8071110B2Activatable clostridial toxinsSTEWARD LANCE E·Filed 2008·Granted Dec 6, 2011·32 cites·13 claims
- 0493US10501731B2Degradable clostridial toxinsALLERGAN INC·Filed 2017·Granted Dec 10, 2019·6 cites·3 claims
- 0593US8841111B2Degradable clostridial toxinsALLERGAN INC·Filed 2013·Granted Sep 23, 2014·9 cites·1 claims
- 0693US8697414B2Degradable clostridial toxinsALLERGAN INC·Filed 2013·Granted Apr 15, 2014·9 cites·2 claims
- 0793US8273358B2Activatable clostridial toxinsSTEWARD LANCE E·Filed 2008·Granted Sep 25, 2012·11 cites·9 claims
- 0888US8512992B2Degradable clostridial toxinsSTEWARD LANCE E·Filed 2011·Granted Aug 20, 2013·5 cites·1 claims
- 0986US9938514B2Methods of intracellular conversion of single-chain proteins into their di-chain formALLERGAN INC·Filed 2016·Granted Apr 10, 2018·3 cites·5 claims
- 1086US2024018500A1Degradable clostridial toxinsALLERGAN INC·Filed 2022·Application pending·0 cites
- 1185US9340813B2Methods of intracellular conversion of single-chain proteins into their di-chain formALLERGAN INC·Filed 2013·Granted May 17, 2016·4 cites·2 claims
- 1284US8546108B2Methods of intracellular conversion of single-chain proteins into their di-chain formGHANSHANI SANJIV·Filed 2011·Granted Oct 1, 2013·7 cites·15 claims
- 1383US8685692B2Degradable clostridial toxinsALLERGAN INC·Filed 2013·Granted Apr 1, 2014·2 cites·1 claims
- 1483US8685693B2Degradable clostridial toxinsALLERGAN INC·Filed 2013·Granted Apr 1, 2014·2 cites·1 claims
- 1582US9297003B2Degradable Clostridial toxinsALLERGAN INC·Filed 2013·Granted Mar 29, 2016·2 cites·2 claims
- 1682US9284545B2Degradable clostridial toxinsALLERGAN INC·Filed 2013·Granted Mar 15, 2016·2 cites·2 claims
- 1782US8697413B2Degradable clostridial toxinsALLERGAN INC·Filed 2013·Granted Apr 15, 2014·2 cites·4 claims
- 1880US9850476B2Degradable clostridial toxinsALLERGAN INC·Filed 2016·Granted Dec 26, 2017·1 cites·1 claims
- 1980US2020190496A1Degradable clostridial toxinsALLERGAN INC·Filed 2019·Application pending·0 cites
- 2069US9279116B2Degradable clostridial toxinsALLERGAN INC·Filed 2013·Granted Mar 8, 2016·0 cites·2 claims
- 2150US2014127784A1Modified clostridial toxins comprising an integrated protease cleavage site-binding domainALLERGAN INC·Filed 2014·Application pending·0 cites
- 2249US2013224178A1Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted EndopepidasesALLERGAN INC·Filed 2013·Application pending·0 cites
- 2348US2013195838A1Methods of Treating Cancer Using Growth Factor Retargeted EndopeptidasesJACKY BIRGITTE P S·Filed 2012·Application pending·0 cites
- 2444US2011189162A1Modified Clostridial Toxins Comprising an Integrated Protease Cleavage Site-Binding DomainALLERGAN INC·Filed 2010·Application pending·0 cites
- 2542US2012207742A1Treatments Using PSMA Ligand EndopeptidasesJACKY BIRGITTE P S·Filed 2012·Application pending·0 cites
- 2640US2012207743A1Inhibiting Aberrant Blood Vessel Formation Using Retargeted EndopeptidasesJACKY BIRGITTE P S·Filed 2012·Application pending·0 cites
- 2740US2012207733A1Treating a Disease of Hyperproliferation Using Retargeted EndopeptidasesJACKY BIRGITTE P S·Filed 2012·Application pending·0 cites
- 2840US2012207704A1Inhibiting Aberrant Blood Vessel Formation Using Growth Factor Retargeted EndopeptidasesJACKY BIRGITTE P S·Filed 2012·Application pending·0 cites
- 2940US2012207734A1Methods of Inhibiting Aberrant Blood Vessel Formation Using Opioid Retargeted EndpeptidasesJACKY BIRGITTE P S·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sanjiv Ghanshani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →